&nbsp;

Discharge-Letter-Template-Colposcopist-To-Primary-Care-Screening-Cessation-FR.docx

Jan 2025

Document

Discharge-Letter-Template-Colposcopist-To-Patient-FR.docx

Jan 2025

Document

Discharge-Letter-Template-Colposcopist-To-Patient-Hysterectomy-FR.docx

Jan 2025

Document

Discharge-Letter-Template-Colposcopist-To-Patient-Screening-Cessation-FR.docx

Jan 2025

Guidelines and Advice

Endometrial Cancer Molecular Testing Recommendations Report

Status: Current
Version: 1

Nov 2024

Regimen

DURV

Cancer Type:

Lung,

Small Cell

Intent: Adjuvant

Drugs Used:

durvalumab (Compassionate)

... Show more tags

Quick Link(s):

Regimen Monograph

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2024

Status: Current
ID: PET 2024-1

Mar 2025

Document

EndometrioidOvarianCancerTreatmentPathwayMap.pdf

Dec 1969

Document

E.1.50-CAR-TReferralWorksheet.pdf

Dec 1969

Regimen

DEXAPOMASELI

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

ODB - General Benefit

dexamethasone

Drugs Used:

dexamethasone,

pomalidomide (Unfunded),

selinexor (Unfunded)

... Show more tags

Quick Link(s):

Regimen Monograph

Regimen

EC+PEMB

Cancer Type:

Breast

Intent: Neoadjuvant

Funding:

New Drug Funding Program

Pembrolizumab - Previously Untreated High-Risk Early-Stage Triple Negative Breast Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Regimen

DOXOTRBC

Cancer Type:

Sarcoma,

Soft Tissue

Intent: Palliative

Drugs Used:

DOXOrubicin,

trabectedin (Unfunded)

... Show more tags